Lentiviral transduction is a popular delivery platform for applications such as CAR-T cell engineering or CRISPR-Cas9 gene editing, as it can transduce both dividing and non-dividing cells and ...

Transduction efficiency (i.e., how much of the genetic material from the packaged lentivirus is transferred and incorporated into the cell) can vary widely. Microfluidics-driven solution ...

Initially, the enriched CD34+ HSCs were transduced with the clinical-grade lentiviral vector CD68-ET3-LV (Fig. S1) according to a double-exposure transduction protocol (Protocol P1 in the ...

Anne Galy, Ph.D., from Inserm, and co-authors, applied a novel lentivirus-based gene therapy strategy in CD34 + hematopoietic progenitor and stem cells (HSPCs) obtained from cord blood.

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction ...

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.

Anne Galy, PhD, from Inserm, and coauthors, applied a novel lentivirus-based gene therapy strategy in CD34+ hematopoietic progenitor and stem cells (HSPCs) obtained from cord blood.

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.